Study of Body Composition in Patients Treated by Adjuvant Hormonal Therapy for Breast Cancer (MetaCa2)

Centre Jean Perrin

Status: Completed

Conditions: Breast Cancer; Hormonal Therapy

Treatments: Other: Body composition measurement

Study type: Interventional

Funder types: Other

Identifiers

NCT02509871

2015-A00633-46

Details and patient eligibility

About

This cross-sectional study of pathophysiology will bring additional informations on body composition of patients treated by adjuvant hormonal therapy for breast cancer. This is a complementary study of Metaca study (AU882).

Enrollment: 33 patients

Sex: Female

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• postmenopausal women
• patients requiring hormonal treatment
• WHO performance status 0-2
• patients initially included in MetaCa (AU882) protocol
• Affiliation to a social security scheme (or be the beneficiary of such a plan)
• patients who signed the informed consent form

Exclusion criteria

• patients witg relapse, with metastases or other cancer
• concurrent treatment with a drug test, or participation in a clinical trial within < 30 days
• patients carrying an electronic medical device (eg pacemaker)
• patients who refused to sign the consent form

Trial design

Primary purpose: Basic Science

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

33 participants in 1 patient group

Body composition measurement

Other group

Description:

DXA, impedance

Treatment:

Other: Body composition measurement